LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

Omnicell Inc

Fermé

SecteurSoins de santé

35.61 0.06

Résumé

Variation du prix de l'action

24h

Actuel

Min

35.36

Max

35.9

Chiffres clés

By Trading Economics

Revenu

-177K

5.5M

Ventes

20M

311M

P/E

Moyenne du Secteur

77.605

77.256

BPA

0.51

Marge bénéficiaire

1.758

Employés

3,670

EBITDA

-935K

29M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+24.02% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

130M

1.5B

Ouverture précédente

35.55

Clôture précédente

35.61

Sentiment de l'Actualité

By Acuity

38%

62%

112 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Omnicell Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 nov. 2025, 21:06 UTC

Principaux Mouvements du Marché

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 nov. 2025, 18:10 UTC

Résultats

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 nov. 2025, 13:10 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 12:00 UTC

Résultats

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 nov. 2025, 10:30 UTC

Résultats

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 nov. 2025, 03:50 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 22:36 UTC

Résultats

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov. 2025, 22:22 UTC

Résultats

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Net $210M >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q EPS $9.89 >CSU.T

7 nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 nov. 2025, 20:59 UTC

Résultats

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 nov. 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 nov. 2025, 20:22 UTC

Résultats

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 nov. 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 nov. 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 nov. 2025, 19:31 UTC

Market Talk
Acquisitions, Fusions, Rachats

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 nov. 2025, 19:17 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 nov. 2025, 19:09 UTC

Résultats

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 nov. 2025, 19:08 UTC

Résultats

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 nov. 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 nov. 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Comparaison

Variation de prix

Omnicell Inc prévision

Objectif de Prix

By TipRanks

24.02% hausse

Prévisions sur 12 Mois

Moyen 44.25 USD  24.02%

Haut 55 USD

Bas 34 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

4

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

24.23 / 30.44Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

112 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat